Get started
SPRINT BIOSCIENCE ABSPRINT BIOSCIENCE ABSPRINT BIOSCIENCE AB

SPRINT BIOSCIENCE AB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

SPRINT chart


Full chart

SPRINT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪113.11 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.274 SEK
Net income (FY)
‪−438.00 K‬ SEK
Revenue (FY)
‪50.48 M‬ SEK
Shares float
‪5.10 M‬
Beta (1Y)
1.10

Employees


Employees (FY)
28
Change (1Y)
−4 −12.50%
Revenue / Employee (1Y)
‪1.80 M‬ SEK
Net income / Employee (1Y)
‪−15.64 K‬ SEK

About SPRINT BIOSCIENCE AB


Sector
Health Technology
CEO
Johan Emilsson
Headquarters
Huddinge
Website
sprintbioscience.com
Founded
2009
ISIN
SE0006343745
FIGI
BBG007H0L9R3
Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non-alcoholic steatohepatitis. The company was founded by Anders Aberg, Par Nordlund, Martin Andersson, Jessica Martinsson, and Kenth Hallberg in 2009 and is headquartered in Huddinge, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SPRINT news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SPRINT is 1.676 SEK — it has increased by 3.46% in the past 24 hours. Watch SPRINT BIOSCIENCE AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SPRINT BIOSCIENCE AB stocks are traded under the ticker SPRINT.
SPRINT stock has risen by 9.11% compared to the previous week, the month change is a 9.26% rise, over the last year SPRINT BIOSCIENCE AB has showed a 24.15% increase.
We've gathered analysts' opinions on SPRINT BIOSCIENCE AB future price: according to them, SPRINT price has a max estimate of 3.00 SEK and a min estimate of 3.00 SEK. Watch SPRINT chart and read a more detailed SPRINT BIOSCIENCE AB stock forecast: see what analysts think of SPRINT BIOSCIENCE AB and suggest that you do with its stocks.
SPRINT reached its all-time high on Aug 4, 2015 with the price of 73.096 SEK, and its all-time low was 0.450 SEK and was reached on Mar 20, 2023. View more price dynamics on SPRINT chart.
See other stocks reaching their highest and lowest prices.
SPRINT stock is 19.13% volatile and has beta coefficient of 1.10. Track SPRINT BIOSCIENCE AB stock price on the chart and check out the list of the most volatile stocks — is SPRINT BIOSCIENCE AB there?
Today SPRINT BIOSCIENCE AB has the market capitalization of ‪117.02 M‬, it has decreased by −7.29% over the last week.
Yes, you can track SPRINT BIOSCIENCE AB financials in yearly and quarterly reports right on TradingView.
SPRINT BIOSCIENCE AB is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
SPRINT net income for the last quarter is ‪−5.21 M‬ SEK, while the quarter before that showed ‪−5.79 M‬ SEK of net income which accounts for 9.96% change. Track more SPRINT BIOSCIENCE AB financial stats to get the full picture.
No, SPRINT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 28.00 employees. See our rating of the largest employees — is SPRINT BIOSCIENCE AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SPRINT BIOSCIENCE AB EBITDA is ‪−18.05 M‬ SEK, and current EBITDA margin is −6.51%. See more stats in SPRINT BIOSCIENCE AB financial statements.
Like other stocks, SPRINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPRINT BIOSCIENCE AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SPRINT BIOSCIENCE AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SPRINT BIOSCIENCE AB stock shows the neutral signal. See more of SPRINT BIOSCIENCE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.